GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Hyphens Pharma International Ltd (SGX:1J5) » Definitions » Total Liabilities

Hyphens Pharma International (SGX:1J5) Total Liabilities : S$44.9 Mil (As of Jun. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Hyphens Pharma International Total Liabilities?

Hyphens Pharma International's Total Liabilities for the quarter that ended in Jun. 2023 was S$44.9 Mil.

Hyphens Pharma International's quarterly Total Liabilities increased from Jun. 2022 (S$39.45 Mil) to Dec. 2022 (S$44.20 Mil) and increased from Dec. 2022 (S$44.20 Mil) to Jun. 2023 (S$44.87 Mil).

Hyphens Pharma International's annual Total Liabilities increased from Dec. 2020 (S$34.28 Mil) to Dec. 2021 (S$44.46 Mil) but then declined from Dec. 2021 (S$44.46 Mil) to Dec. 2022 (S$44.20 Mil).


Hyphens Pharma International Total Liabilities Historical Data

The historical data trend for Hyphens Pharma International's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyphens Pharma International Total Liabilities Chart

Hyphens Pharma International Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Total Liabilities
Get a 7-Day Free Trial 35.82 36.06 34.28 44.46 44.20

Hyphens Pharma International Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.74 44.46 39.45 44.20 44.87

Hyphens Pharma International Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Hyphens Pharma International's Total Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=40.074+(3.33+0.793
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=44.2

Total Liabilities=Total Assets (A: Dec. 2022 )-Total Equity (A: Dec. 2022 )
=114.469-70.272
=44.2

Hyphens Pharma International's Total Liabilities for the quarter that ended in Jun. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=41.486+(2.651+0.73700000000001
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=44.9

Total Liabilities=Total Assets (Q: Jun. 2023 )-Total Equity (Q: Jun. 2023 )
=115.331-70.457
=44.9

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hyphens Pharma International Total Liabilities Related Terms

Thank you for viewing the detailed overview of Hyphens Pharma International's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Hyphens Pharma International (SGX:1J5) Business Description

Traded in Other Exchanges
N/A
Address
16 Tai Seng Street, Level 4, Singapore, SGP, 534138
Hyphens Pharma International Ltd is a pharmaceutical company. Its segments include Specialty Pharma Principals segment; Proprietary Brands segment and Medical Hypermart and Digital segment. Specialty pharma principals segment engages in the business of selling and marketing specialty pharmaceutical products. Proprietary Brands segment develops, markets and sells own proprietary range of dermatological products and health supplement products through Hyphens and Ocean Health Singapore. Medical Hypermart and Digital is engaged in the wholesale of pharmaceuticals and medical supplies in Singapore through Pan-Malayan.

Hyphens Pharma International (SGX:1J5) Headlines

No Headlines